All cervical cancer articles
-
NewsA therapeutic HPV vaccine could eliminate precancerous cervical lesions
A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical lesions, according to the results from a phase II clinical trial.
-
NewsChanges in microbiome predict risk for sexually transmitted disease
Researchers have found that bacterial vaginosis consists of two subtypes—one of which significantly increases the risk of developing chlamydia infections.
-
NewsStudy links vaginal microbiome differences to higher cervical cancer rates in Native American women
Researchers found that protective microorganisms were present at higher rates in non-Native women compared with Native American women.
-
NewsCervical cancer deaths in young women plummet after introduction of HPV vaccine
Cervical cancer deaths have plunged dramatically among women under age 25, and researchers believe this is likely due to HPV vaccination.
-
NewsHPV vaccination switch to 1-dose gender-neutral approach
Canadian vaccination programs could switch to a 1-dose gender-neutral human papillomavirus (HPV) vaccination approach and eliminate cervical cancer, suggests new modelling.
-
NewsCall for global gender-neutral HPV vaccination by 2030
A new global initiative is calling for a more ambitious, ethical and equitable approach that will see more boys and men gain access to cancer-preventing Human Papillomavirus (HPV) vaccination and protect more people worldwide from HPV-related cancers.
-
NewsNew vaccine against cervical cancer combines prophylactic and therapeutic activity
Scientists at the German Cancer Research Center (DKFZ) have developed a completely new vaccination concept with a new vaccine against cancer-causing human papillomaviruses (HPV).
-
NewsResearchers develop noninvasive urine test for early detection of cervical cancer virus proteins
A new urine test can detect HPV16 E7 proteins, which are critical markers of cervical cancer risk, at extremely low levels, meaning women may be able to screen for cervical cancer without the discomfort and inconvenience of a traditional Pap test.
-
News HPV testing for cervical cancer may be safe at longer intervals than recommended by current guidelines
The risk of detecting cervical precancer eight years after a negative HPV screening was found to be similar to the risk after three years (the commonly recommended screening interval) after a negative cytology screening.
-
NewsHPV vaccine prevents most cervical cancer cases in more deprived groups, major study shows
The human papillomavirus, or HPV, vaccine is cutting cases of cervical cancer right across the socio-economic spectrum, with most cases being prevented in more deprived groups, according to a major study funded by Cancer Research UK. Source: NIAID Colorized electron micrograph of HPV virus particles harvested and ...
-
NewsCervical cancer vaccine very effective in reducing HPV-related disease, but huge variations between countries in coverage
Although evidence is clear that HPV vaccination is reducing cervical cancer incidence and mortality and HPV-related disease, there are high variations in coverage globally, including among high-income countries.
-
NewsResearchers identify new genetic risk factors for persistent HPV infections
A new finding suggests that certain women may have a genetic susceptibility for persistent or frequent HPV infections, potentially raising their risk of getting cervical cancer from a high-risk HPV infection.